Systematic reviews consistently show it improves outcomes for rotator cuff tendinopathy, frozen shoulder, and post-surgical recovery
PMID: 34459213 DOI: 10.1161/CIRCULATIONAHA.121.056824 Packer M et al (2022): Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
PubMed pubmed.ncbi.nlm.nih.gov [41] Semaglutide for the treatment of obesity PubMed pubmed.ncbi.nlm.nih.gov [42] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [43] The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Adolescents Without Diabetes Mellitus: A Systematic Review and Meta-Analysis PubMed pubmed.ncbi.nlm.nih.gov [44] A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point
Recent advances in high-throughput sequencing and metabolomics have elucidated mechanisms linking gut microbiota and associated metabolites to kidney and brain health, revealing the role of microbial diversity and metabolite profiles in disease outcomes
The loss of potency is significant and not worth the risk to your studys integrity
This article explores how GLP-1 use is reshaping visit cadence and what clinicians should consider when determining optimal follow-up strategies
